Serial Number:
97353471
Mark:
ULTRAGENYX GENE THERAPY
Status:
Abandoned-Failure to Respond
Status Date:
03-31-2023
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, inflammatory, autoimmune, musculoskeletal, ophthalmologic, respiratory, and hematologic diseases and disorders Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo laboratory use in gene therapy Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of genetic diseases and disorders; providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, respiratory, and hematologic diseases and disorders Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays
Mark Description:
The mark consists of the word "ultragenyx" in lower case letters above the words "gene therapy". The formative "ultra" and the words "gene therapy" are purple and the formative "genyx" is green. The letter "x" in "genyx" is stylized and features an enlongated stroke reaching above and below the word "ultragenyx". A gray hexagon is below the formative "ultra" and to the left of the words "gene therapy." A double helix, one strand of which is purple and one strand of which is green, is vertically oriented inside the gray hexagon.
Class:
Medical services
Type of Mark:
Trademark
Published for Opposition Date:
N/A
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
03-15-2023
Business Name:
COOLEY LLP
Correspondent Name:
